FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

69050006: Physostigmine salicylate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
114694015 Physostigmine salicylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
114695019 Eserine salicylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
44181000188118 éséridine salicylate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
457921000241111 salicylate de physostigmine (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
808952011 Physostigmine salicylate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
833451000172119 salicylate de physostigmine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Physostigmine salicylate Has disposition (attribute) Reversible anticholinesterase true Inferred relationship Some
Physostigmine salicylate est un(e) (attribut) Physostigmine (substance) false Inferred relationship Some
Physostigmine salicylate est un(e) (attribut) physostigmine false Inferred relationship Some
Physostigmine salicylate Has disposition (attribute) Acetylcholine receptor agonist (disposition) false Inferred relationship Some
Physostigmine salicylate Has disposition (attribute) Cholinesterase inhibitor (disposition) false Inferred relationship Some
Physostigmine salicylate est un(e) (attribut) Miotic (substance) true Inferred relationship Some
Physostigmine salicylate est un(e) (attribut) Phenylcarbamate (substance) true Inferred relationship Some
Physostigmine salicylate est un(e) (attribut) Reversible anticholinesterase true Inferred relationship Some
Physostigmine salicylate Is modification of (attribute) Physostigmine (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution Has basis of strength substance (attribute) True Physostigmine salicylate Inferred relationship Some 2
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution Has precise active ingredient True Physostigmine salicylate Inferred relationship Some 2
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Has precise active ingredient True Physostigmine salicylate Inferred relationship Some 1
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Has basis of strength substance (attribute) True Physostigmine salicylate Inferred relationship Some 1
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has precise active ingredient True Physostigmine salicylate Inferred relationship Some 1
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has basis of strength substance (attribute) True Physostigmine salicylate Inferred relationship Some 1
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Has basis of strength substance (attribute) True Physostigmine salicylate Inferred relationship Some 2
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Has precise active ingredient True Physostigmine salicylate Inferred relationship Some 2
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Has basis of strength substance (attribute) True Physostigmine salicylate Inferred relationship Some 2
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Has precise active ingredient True Physostigmine salicylate Inferred relationship Some 2
Physostigmine salicylate 1mg/mL injection solution ampule (product) a pour principe actif (attribut) False Physostigmine salicylate Inferred relationship Some

This concept is not in any reference sets

Back to Start